# Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

> **NCT02793882** · — · COMPLETED · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 218 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 18F-Fluorocholine PET/CT

## Key facts

- **NCT ID:** NCT02793882
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2017-03-25
- **Final completion:** 2017-04-24
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793882, "Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02793882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*